Recombinant human thyroid-stimulating hormone-aided remnant ablation achieves a response to treatment comparable to that with thyroid hormone withdrawal in patients with clinically relevant lymph node metastases.

Pitoia, Fabián; Abelleira, Erika; Cross, Graciela

Pitoia, Fabián; Abelleira, Erika; Cross, Graciela.

Afiliação

Pitoia F; Division of Endocrinology, Hospital de Clínicas, University of Buenos Aires, Buenos Aires, Argentina.
Abelleira E; Division of Endocrinology, Hospital de Clínicas, University of Buenos Aires, Buenos Aires, Argentina.
Cross G; Division of Endocrinology, Hospital de Clínicas, University of Buenos Aires, Buenos Aires, Argentina.

Eur Thyroid J ; 3(4): 264-71, 2014 Dec.

Article em En | MEDLINE | ID: mdl-25759804

Palavras-chave

Lymph node metastases; Recombinant human thyroid-stimulating hormone; Remnant ablation; Thyroid cancer; Thyroid hormone withdrawal

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur Thyroid J Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Argentina País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google